Q&A With Mark Freedman, MD, of Ottawa Hospital: Study Results show Benefits of Teriflunomide in Multiple Sclerosis Treatment

As a treatment for multiple sclerosis teriflunomide has shown benefits over a long development period and has proven effective in the treatment of patients with the relapsing-remitting form of the condition.

Mark Freedman, MD, FAAN, from Ottawa Hospital discussed how the medication works and what its safety profile is during the American Academy of Neurology Annual Meeting in Washington DC. The medication is indicated for reducing relapses, slowing disability and reducing MRI activity after being in development for more than a decade.